Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Atopic Dermatitis – Pipeline Review, H1 2017

Monday, March 20, 2017 2:19
% of readers think this story is Fact. Add your two cents.

(Before It's News)

 

Ethocle Reports has published its latest Market Research Report on Atopic Dermatitis – Pipeline Review, H1 2017. Atopic Dermatitis – Pipeline Review, H1 2017, provides an overview of the Atopic Dermatitis (Dermatology) pipeline landscape. Browse market data tables and figures.

 

                                                                                                                  Published On: 15-Mar-2017 | Pages: 374

Summary

Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis – Pipeline Review, H1 2017, provides an overview of the Atopic Dermatitis (Dermatology) pipeline landscape.

Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from scratching. Risk factors include family history of eczema, allergies, hay fever or asthma and gender.

Capture.PNG     d.PNG    dd.PNG

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Atopic Dermatitis – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Atopic Dermatitis (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Atopic Dermatitis (Dermatology).

- The pipeline guide reviews pipeline therapeutics for Atopic Dermatitis (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Atopic Dermatitis (Dermatology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

Table of Contents

Introduction

Global Markets Direct Report Coverage

Atopic Dermatitis – Overview

Atopic Dermatitis – Therapeutics Development

Pipeline Overview

Products under Development by Companies

Atopic Dermatitis – Therapeutics Assessment

Assessment by Target

Assessment by Molecule Type

Atopic Dermatitis – Companies Involved in Therapeutics Development

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.